Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arthritis & Rheumatic Disease Specialties (ARDS) is a premier clinical research site and medical practice based in Aventura, Florida, specializing in the diagnosis and treatment of complex autoimmune and inflammatory conditions. Led by Dr. Norman B. Gaylis, the center operates a dedicated research division that conducts Phase 1 through Phase 4 clinical trials for global pharmaceutical and biotechnology sponsors. The facility is equipped with advanced diagnostic imaging, an on-site laboratory, and a comprehensive infusion center to support clinical study protocols. ARDS has contributed to the clinical development and FDA approval of numerous blockbuster rheumatology therapies, including various biologics and small molecule inhibitors. By integrating clinical care with cutting-edge research, ARDS provides patients with access to emerging treatments while advancing the field of rheumatological medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arthritis & Rheumatic Disease Specialties Research.